EDIT: Editas Medicine Inc Bozor narxining sof foydaga nisbati

Editas (EDIT) brendining ramzi va logotipi

Editas Medicine, Inc. (EDIT) o'zining tadqiqot markazlarini Massachusets shtatida saqlaydi, dori ishlab chiqarishni kengaytirish esa AQSh bio-zavodlariga tayanadi. Neytral geosiyosat va sanksiyalardan himoya ilmiy rivojlanish uchun barqaror asos yaratadi. GURU.Markets platformasidagi qimmatli qog'ozlarning ushbu narx harakati -3.90 miqdoridagi P/E koeffitsiyentini ko'rsatadi, asosiy CRISPR patentlariga egalik qilish esa kompaniyaga qonni davolashning noyob usullarini ishlab chiqish imkonini beradi.

Editas Medicine (EDIT): Narxning foydaga nisbati 04.07.2022dan 18.11.2026gacha

Editas Medicine, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning jamlanma tahlili:EDIT (Editas Medicine)
Editas Medicine, Inc. yetakchi tovari

Editas Medicine, Inc. (EDIT) kompaniyasining uzoq muddatli ishonchliligi uning CRISPR texnologiyalarining eksklyuzivligi va raqobatchilar uchun kirishning yuqori to'siqlari bilan asoslangan. P/E ko'rsatkichi biznes qiymatini uning sof foydasiga nisbatan belgilaydi va topilgan har bir dollarning bozor bahosini aks ettiradi. Emitentning P/E koeffitsiyentini tahlil qilish orqali investor aktiv haddan tashqari sotib olinganini yoki yashirin o'sish potentsialiga ega ekanligini aniqlashi mumkin. Noyob patent portfelining ushbu hisob-kitoblarga integratsiyasi kompaniyaning fundamental barqarorligini tasdiqlaydi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|QURE - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori MGTX|Biznesning o‘zini qoplash muddati regenxbio.com|P/E multiplikatori SLDB (Solid Biosciences Inc)|OCGN: Narx-foyda multiplikatori|PACB - Narxning foydaga nisbati|Benitec (BNTC) - Narx-foyda koeffitsiyenti|DSGN: P/E multiplikatori|RCKT: Bozor narxining sof foydaga nisbati|FDMT (4D Molecular Therapeutics, Inc.) - P/E multiplikatori|lexeotx.com (LXEO) - Biznesning o‘zini qoplash muddati|P/E multiplikatori KRRO|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati